Sign in

CIK 0001359931

  • Non-accelerated filer
  • Smaller reporting company

Protara Therapeutics, Inc.

Sign in to watch
Ticker
TARA
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Entity type
Operating
EIN
204580525
Phone
+1 646-844-0337
Business address
345 PARK AVENUE SOUTH, 3RD FLOOR, NEW YORK, NY, 10010
Former names
Protara Therapeutics, Inc., ArTara Therapeutics, Inc., PROTEON THERAPEUTICS INC
  1. 4 Derivatives Options or other derivatives
  2. 4 Derivatives Options or other derivatives
  3. 4 Derivatives Options or other derivatives
  4. 4 Derivatives Options or other derivatives
  5. 4 Derivatives Options or other derivatives
  6. 4 Returned to the company President and CEO returned 10,000 shares (to the company)
  7. 4 Grant or award Senior VP of Marketing acquired 5,531 shares (grant or award)
  8. 4 Grant or award VP, Legal and Secretary acquired 3,934 shares (grant or award)
  9. 4 Grant or award Sr VP, CFO, Treasr, Asst Secy acquired 3,934 shares (grant or award)
  10. 4 Grant or award SVP and Chief Medical Officer acquired 3,934 shares (grant or award)
  11. 4 Open-market buy SVP and Chief Medical Officer bought 12,000 shares at $1.88 ($22,560)
  12. 4 Returned to the company President and CEO returned 10,000 shares (to the company)
  13. 4 Open-market buy Director bought 110,557 shares at $1.75 ($193,475)
  14. 4 Returned to the company President and CEO returned 10,000 shares (to the company)
  15. 4 Open-market buy Sr VP, CFO, Treasr, Asst Secy bought 295 shares at $1.69 ($499)
  16. 4 Grant or award Director acquired 53,312 shares (grant or award)
  17. 4 Returned to the company President and CEO returned 10,000 shares (to the company)
  18. 4 Returned to the company President and CEO returned 10,000 shares (to the company)
  19. 4 Derivatives Options or other derivatives
  20. 4 Derivatives Options or other derivatives

Page 14 of 20 · 382 filings